IVF with Gender Selection Using ICSI in Cairo, Egypt

• Estimated cost range: IVF with sex selection packages in Cairo generally cost between $6,000 and $10,500 USD, depending on hormone stimulation protocols, medication dosage, and the total number of embryos tested.

• Primary technology: Advanced PGD Gender Selection in Cairo Egypt screens chromosomes for numerical abnormalities while identifying embryo gender with over 99.9% accuracy prior to transfer.

• Trip duration: Intended parents typically spend approximately 18 to 21 days in Cairo to complete ovarian stimulation, egg retrieval, ICSI fertilization, embryo culture, genetic testing, and fresh or frozen transfer planning.

• Healthcare standards: Leading Cairo fertility centers offer state-of-the-art embryology labs adhering to rigorous international laboratory safety, cleanroom protocols, and quality control standards.

• Procedure goal: The primary goals of Family Balancing IVF in Cairo Egypt are to maximize healthy pregnancy rates, screen against hereditary chromosomal disorders, and assist families with gender identification.

• Travel preparation: Patients should assemble previous reproductive test results, hormone panels, infectious disease screenings, and travel documentation prior to starting treatment.

• Initial fertility specialist consultation, ultrasound evaluation, and treatment protocol setup

• Ovarian stimulation monitoring, blood work, and serial ultrasound follicle tracking

• Transvaginal egg retrieval procedure performed under light anesthesia/sedation

• Semen preparation and ICSI Fertility Treatment in Cairo Egypt

• Embryo culture in specialized incubators up to the blastocyst stage (Day 5/6)

• Laser embryo biopsy and PGD Gender Selection in Cairo Egypt screening

• Fresh or Frozen Embryo Transfer (FET) procedure

• Post-transfer hormonal support medications (initial supply)

• Comprehensive embryology and genetic test reporting

• International airfare and travel arrangements to Cairo, Egypt

• Entry visa fees and travel medical insurance coverage

• Hotel accommodation, daily meals, and personal living expenses in Cairo

• Genetic screening fees for additional embryos beyond the package limit

• Annual long-term embryo cryopreservation and storage renewal fees

• Treatments for unexpected medical complications or unrelated medical conditions

• Subsequent frozen embryo transfer cycles if the initial attempt is unsuccessful

• Couples seeking family balancing (desiring a child of a specific sex to balance their family)

• Intended parents wishing to screen embryos for numerical or structural chromosomal abnormalities

• Carriers of X-linked genetic disorders requiring gender determination to prevent hereditary disease transmission

• Patients with prior unexplained IVF failure or recurrent pregnancy loss histories

• Individuals with adequate ovarian reserve parameters and sperm characteristics suitable for ICSI

• Hormonal profile blood test results (AMH, FSH, LH, Estradiol, Progesterone, TSH)

• Recent pelvic ultrasound scan report detailing antral follicle count (AFC) and uterine status

• Comprehensive semen analysis report for the male partner

• Infectious disease screening panel (HIV, Hepatitis B, Hepatitis C, Syphilis)

• Medical summary documenting past reproductive history or prior IVF attempts, if applicable

• Karyotype testing reports (if existing hereditary or chromosomal conditions are documented)

1. Ovarian stimulation: Daily hormonal injections stimulate the development of multiple mature egg follicles over 10 to 12 days.

2. Egg retrieval & ICSI: Mature eggs are retrieved under mild sedation, followed immediately by ICSI sperm injection for optimal fertilization.

3. Blastocyst culture: Fertilized eggs are cultured in advanced embryology incubators until reaching the Day 5 or Day 6 blastocyst stage.

4. Embryo biopsy & PGD analysis: Trophectoderm cells are safely biopsied from each blastocyst to evaluate chromosomal composition and determine gender.

5. Embryo selection: Genetically healthy embryo(s) matching the desired family balancing gender are selected for transfer.

6. Embryo transfer: The designated embryo is gently placed into the uterus, followed by supportive hormonal treatment and pregnancy monitoring.

1. Before travel: Remote medical consultations occur, diagnostic records are reviewed, and the individual stimulation protocol is arranged.

2. Days 1–2 (Arrival & Baseline Test): Arrival in Cairo, baseline ultrasound evaluation, and initiation of stimulation medications on Day 2 or 3 of the cycle.

3. Days 3–10 (Stimulation & Monitoring): Regular clinic visits every 2 to 3 days for follicle response monitoring and dosage adjustments.

4. Days 12–14 (Trigger Shot & Retrieval): Trigger shot administration, transvaginal egg harvesting, semen processing, and ICSI fertilization.

5. Days 15–19 (Culture & PGD Testing): Embryo growth tracking, Day 5 blastocyst biopsy, and PGD laboratory sex/chromosomal determination (2–4 days processing).

6. Days 19–21 (Embryo Transfer & Return): Guided transfer of chosen healthy embryo(s), post-transfer rest, medication guidance, and return travel approval.

• Plan a total single trip duration of roughly 3 weeks for complete cycle execution.

• Allow post-retrieval recovery time to verify physical well-being prior to embryo transfer.

• Consult with your treating physician in Cairo regarding flight authorization and travel clearance.

• Blood pregnancy testing (Beta hCG) is conducted 10 to 12 days post-transfer and can be performed in Cairo or back home.

• Rest comfortably at your hotel for several hours following egg retrieval and transfer procedures

• Take all prescribed progesterone and luteal support medications precisely as instructed

• Maintain consistent hydration and consume balanced, protein-rich meals

• Avoid heavy lifting, high-impact workouts, strenuous activities, and hot baths after transfer

• Engage in light daily activities while avoiding physical exhaustion or heavy physical stress

• Monitor for any unexpected symptoms such as sharp pelvic pain, excessive cramping, or heavy bleeding

• Perform the quantitative Beta hCG blood test on the scheduled date to confirm pregnancy

• Maintain contact with your clinical team for medication guidance based on blood test results

• Continue supportive medications until advised to taper by your fertility specialist during early pregnancy

• Schedule an initial obstetric ultrasound scan around weeks 6 to 8 to verify clinical viability and heartbeat

• Transition routine prenatal care to your local obstetrician once pregnancy progress is established

• Ovarian Hyperstimulation Syndrome (OHSS) stemming from stimulation medication response

• Mild pelvic soreness, light spotting, or discomfort following egg collection

• Possibility that limited or no embryos develop to the blastocyst stage suitable for testing

• Risk that screened embryos present chromosomal abnormalities or do not match the preferred gender

• Minimal risk (<1%) of embryo damage during the micro-biopsy or freezing processes

• Implantation failure or early pregnancy loss despite normal genetic testing results

• Multiple pregnancy risks if more than one embryo is transferred during a cycle

• High precision in gender identification for embryos successfully evaluated via PGD screening.

• Lowered risk of chromosomal disorders and early miscarriage through selection of euploid embryos.

• Enhanced implantation confidence per embryo transfer relative to untested IVF cycles.

• Clear medical expectations provided by specialists based on patient diagnostic parameters.

1. How accurate is PGD gender selection in Cairo, Egypt?

Preimplantation Genetic Diagnosis (PGD) offers over 99.9% accuracy for gender identification by examining sex chromosomes directly in embryo biopsy samples.

2. What is the average cost of an IVF package with gender selection in Cairo?

Comprehensive packages in Cairo generally range between $6,000 and $10,500 USD, covering fertility consultations, ICSI, blastocyst culture, PGD testing, and embryo transfer.

3. How many days do we need to stay in Cairo for treatment?

Patients should plan to remain in Cairo for approximately 18 to 21 days to complete the full cycle from stimulation to embryo transfer.

4. Does embryo biopsy for PGD cause harm to the embryo?

When performed by skilled embryologists at blastocyst stage (Day 5/6), trophectoderm biopsy carries a very low risk (<1%) of impairing embryo development.

5. Can we select the gender if healthy embryos of both sexes are available?

Yes. When healthy, chromosomally normal embryos of both genders are identified, parents can choose which embryo to transfer for family balancing.

6. What happens if none of the embryos are of the desired gender?

Your fertility physician will review all genetic reports with you. Options include transferring a healthy embryo of the available gender, freezing embryos, or considering a new cycle.

7. What initial medical tests are required before traveling to Cairo?

Patients submit baseline hormone panels (AMH, FSH, Estradiol), pelvic ultrasound reports, infectious disease panels, and semen analysis reports prior to arrival.

8. Is ICSI required for PGD gender selection cycles?

Yes. ICSI is standard in PGD cycles to prevent extraneous sperm DNA contamination from interfering with accurate genetic analysis results.

9. Are frozen embryo transfers effective for PGD cycles?

Yes. Frozen embryo transfer (FET) yields high success rates by allowing the uterine lining to return to a natural state post-stimulation before placement.

10. How can international patients coordinate IVF with gender selection in Cairo?

Global patients begin by forwarding their medical history and test results for doctor review, after which coordinators organize protocol scheduling and logistics.

Start Your IVF Treatment Planning in Cairo

Building your family through advanced reproductive technology requires precise medical expertise, cutting-edge genetics, and individual care. If you are exploring Family Balancing in Cairo Egypt, submit your medical records for professional review and package planning.

Medical Disclaimer

This content is provided for general informational and educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider for personal diagnostic assessment, treatment options, and fertility planning decisions.

• American Society for Reproductive Medicine (ASRM) – Reproductive Medicine and PGT Resources

• World Health Organization (WHO) – Infertility and Reproductive Health Information

• American College of Obstetricians and Gynecologists (ACOG) – Reproductive Health and Fertility Resources

• Human Fertilisation and Embryology Authority (HFEA) – IVF, Fertility Treatment, and Embryo Testing Information

• National Institutes of Health (NIH) – Reproductive Health and Medical Research Resources